(Q33840089)

29 July 2017

1 reference

title

Role of newer azoles in surgical patients (English)

1 reference

29 July 2017

Patterson TF

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

29 July 2017

published in

Journal of Chemotherapy

1 reference

29 July 2017

volume

11

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

504-512

1 reference

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Risk factors for invasive fungal infections complicating orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.6.504

10.1179/JOC.1999.11.6.504

21 January 2018

Identifiers

DOI

1 reference

release_mxu6gwguy5cqreysehvmhesxoa

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mxu6gwguy5cqreysehvmhesxoa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference